{"id":817348,"date":"2025-02-25T07:24:33","date_gmt":"2025-02-25T12:24:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/"},"modified":"2025-02-25T07:24:33","modified_gmt":"2025-02-25T12:24:33","slug":"voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/","title":{"rendered":"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LEXINGTON, Mass., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the Company will participate in multiple upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">TD Cowen 45<sup>th<\/sup> Annual Health Care Conference, in\u00a0Boston, including a fireside chat at\u00a01:50 p.m. ET\u00a0on\u00a0March 3, 2025<\/li>\n<li style=\"margin-bottom:8pt\">Stifel 2025 Virtual CNS Forum, including a fireside chat at 11:00 a.m. ET on March 19, 2025<\/li>\n<\/ul>\n<p>Webcasts of the presentations will be available and may be accessed from the Investors section of Voyager\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YVWl7ju4A_G1PTDG9ll2QRiRFmK3BHqALFjt6SQih9f-Dxy0AsqMNFy6lOaIG0BqsYOfqk9-9qgE52y_DfGspiXT8mtK9HOryrZTrjyNOK4CytAkojrezWoRSfpgh2RbjXWqLoSFXUbNRPShdjrlOD5fo-Cv-71k7hhsR1rij-HeviCDYwSl08mUpN9UHBATpUfeb41QpTGEOlWWo7K5xazpsmQ5o6yF7jqBIS5nbvRizDSHiUwvzsHr47BgrovKO74Yek7KzR0kYlYc98loVAofTKzBva9KPaaKgb_ls5I=\" rel=\"nofollow\" target=\"_blank\">ir.voyagertherapeutics.com<\/a>. A replay of the webcasts will be archived on the Company\u2019s website for at least 30 days.<\/p>\n<p>\n        <strong>About\u00a0Voyager Therapeutics<\/strong><br \/>\n        <br \/>Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of \u2013 and ultimately cure \u2013 neurological diseases. Our pipeline includes programs for Alzheimer\u2019s disease, amyotrophic lateral sclerosis (ALS), Parkinson\u2019s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER\u2122 AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease;\u00a0Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S-KJtK89u5SAQw0-UFoWp03l8CzDMNFovndlw7-ZlIKW_S3cFRhZn0Re3vyApqacuI3IKuBJAtwVPcBj33nfcAxPsFi7L8Rjz9FruDe4cX6Yv5-9PwkpiChBJeeCQEMuPz_lxLoix6IE7Ef8myCdsV8eWf7D7ya2ggydo8L-8A7J5S7sauQBEFoVlWMHiSJ9wPmPYI7ovSu9cPlqQ846lntAFmacNWI5Wh9JBa04_Ng4x5cz2O6zLfqyqa9ksP01sBDIAjArFyGxE0x6cGp4CeiYl0_5GBLfTY4RjEA4wEg=\" rel=\"nofollow\" target=\"_blank\">www.voyagertherapeutics.com<\/a>.<\/p>\n<p>\n        <em>Voyager Therapeutics<\/em><br \/>\n        <sup><br \/>\n          <em>\u00ae<\/em><br \/>\n        <\/sup><br \/>\n        <em>\u00a0is a registered trademark, and TRACER\u2122 is a trademark, of\u00a0Voyager Therapeutics, Inc.\u00a0<\/em>\n      <\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Trista Morrison, NACD.DC,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VumyYWW5Dh2YAk9vA6aERtPMdkh6R4DeV6usxQECKiYSOufGEM6-QpOb7W_sI_pXtOELsgy4A3U_7rXdPRKQlTL2s2E71PwcD2cG0adLHQ9TI7lJwCxAqTPAAIuUejlS1lD0aKnB_Irl6GGV3N_lAuBVKpqSchv0qTtTKbNOKgE8SV1y7-qjhdJhcS8yh9srGzMhKWOpU9Nxhvmjtbr5e4UjuHYDBG6Q_8T_ScyY83-djWia-bISlY6_5qDOxwJTjsu_hbedfI-geiF9L_TScg==\" rel=\"nofollow\" target=\"_blank\">tmorrison@vygr.com<\/a><br \/>Investors:\u00a0Mike Hencke,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jYouEFrGHYOtut1ukn_GX1XA8GG-XbXy5fLG6hAPzd9kZ3bIYz_3ARpzr5tW4o4UpUoWzP025UyrT1TMdMlLH5xFakNM7s-t_S9Vo9ZDras=\" rel=\"nofollow\" target=\"_blank\">mhencke@kendallir.com<\/a>\u00a0\u00a0 <br \/>Media:\u00a0Brooke Shenkin,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QexbzAWB9rHib0Jl6UsOnENxF6c3WqA5BI010FECtuf8tLcwuGc1GRCHbQn90EmXkqRsRA81CPD5YJbobpbEnj4vKBNKW5pL-kUpx-we6dGJ4FfZ4985oJi37G_LU_TKXo_cCgr2RkPdpoV-ppQ_xWPF3Bt-hlUp7yyOba_yoarrRaBGTDyl-0kYPrsRX_lpQ2sfFxAuI0s7RpNTIRrhe93Cpa-4plcb9N8YGxheL_liqpI_VY7IAdSuQ_GkWrGvmV0iFmZl32dzB8DkHRZ2Ow==\" rel=\"nofollow\" target=\"_blank\">brooke@scientpr.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NWE0ZTZlOGItNGQwMy00YmNmLWEyYjgtYjQ4M2I4MjBkMWUwLTEwMzA0MTM=\/tiny\/Voyager-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the Company will participate in multiple upcoming investor conferences: TD Cowen 45th Annual Health Care Conference, in\u00a0Boston, including a fireside chat at\u00a01:50 p.m. ET\u00a0on\u00a0March 3, 2025 Stifel 2025 Virtual CNS Forum, including a fireside chat at 11:00 a.m. ET on March 19, 2025 Webcasts of the presentations will be available and may be accessed from the Investors section of Voyager\u2019s website at ir.voyagertherapeutics.com. A replay of the webcasts will be archived on the Company\u2019s website for at least 30 days. About\u00a0Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-817348","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the Company will participate in multiple upcoming investor conferences: TD Cowen 45th Annual Health Care Conference, in\u00a0Boston, including a fireside chat at\u00a01:50 p.m. ET\u00a0on\u00a0March 3, 2025 Stifel 2025 Virtual CNS Forum, including a fireside chat at 11:00 a.m. ET on March 19, 2025 Webcasts of the presentations will be available and may be accessed from the Investors section of Voyager\u2019s website at ir.voyagertherapeutics.com. A replay of the webcasts will be archived on the Company\u2019s website for at least 30 days. About\u00a0Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human &hellip; Continue reading &quot;Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T12:24:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences\",\"datePublished\":\"2025-02-25T12:24:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/\",\"name\":\"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=\",\"datePublished\":\"2025-02-25T12:24:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Market Newsdesk","og_description":"LEXINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the Company will participate in multiple upcoming investor conferences: TD Cowen 45th Annual Health Care Conference, in\u00a0Boston, including a fireside chat at\u00a01:50 p.m. ET\u00a0on\u00a0March 3, 2025 Stifel 2025 Virtual CNS Forum, including a fireside chat at 11:00 a.m. ET on March 19, 2025 Webcasts of the presentations will be available and may be accessed from the Investors section of Voyager\u2019s website at ir.voyagertherapeutics.com. A replay of the webcasts will be archived on the Company\u2019s website for at least 30 days. About\u00a0Voyager Therapeutics Voyager Therapeutics, Inc.\u00a0(Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human &hellip; Continue reading \"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-25T12:24:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences","datePublished":"2025-02-25T12:24:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/","name":"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=","datePublished":"2025-02-25T12:24:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzg4MSM2Nzc2NDQ1IzIwMTg4NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/voyager-therapeutics-to-present-at-multiple-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=817348"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817348\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=817348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=817348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=817348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}